AbbVie Mergers and Acquisitions Summary

Life ScienceCompany

AbbVie has acquired 5 companies, including 3 in the last 5 years. It has also divested 1 asset.

AbbVie’s largest acquisition to date was in 2019, when it acquired Allergan for $63.0B. It’s largest disclosed sale occurred in 2020, when it sold Rare Pediatric Disease Priority Review Voucher to United Therapeutics for $105M. AbbVie has acquired in 4 different US states. The Company’s most targeted sectors include life science (100%).

Join Mergr and gain access to AbbVie’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity6
    • M&A Buy Activity5
    • M&A Sell Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1
  • M&A Advisors 5


AbbVie, Inc.

1 North Waukegan Road,
North Chicago, Illinois 60064
United States,
(847) 932-7900

AbbVie is a global, research-based biopharmaceutical company. AbbVie develops and markets advanced therapies that address complex and serious diseases. AbbVie's products are focused on treating conditions such as chronic autoimmune diseases, including rheumatoid arthritis, psoriasis, and Crohn's disease; low testosterone; HIV; endometriosis; thyroid disease; Parkinson's disease; and complications associated with chronic kidney disease and cystic fibrosis, among other health conditions. AbbVie was formed in 2012 and is based in North Chicago, Illinois.

M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (0.4/yr) # 3 - - 2 - - 5
vol $27.2B $63.0B $90.2B
Sell (0.2/yr) # - - - - 1 - 1
vol $105M $105M

Most Recent M&A

Company Date Value Type
Rare Pediatric Disease Priority Review Voucher (PPRV) 2020-12-28 105M USD Divestiture
, United States
Mavupharma 2019-07-15 - Add-on Acquisition
Kirkland, Washington ·
Allergan plc 2019-06-25 63.0B USD Add-on Acquisition
Parsippany, New Jersey ·
Stemcentrx, Inc. 2016-04-28 5.8B USD Add-on Acquisition
South San Francisco, California ·
Rare Pediatric Disease Priority Review Voucher (PPRV) 2015-08-19 350M USD Divestiture
, United States
Pharmacyclics, Inc. 2015-03-04 21.0B USD Add-on Acquisition
Sunnyvale, California ·
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Allergan plc 2019-06-25 Zenpep 2020-01-27 1
Parsippany, New Jersey · Parsippany, New Jersey ·

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 5 (100%) 90.2B (100%) 1 (100%) 105M (100%)
Total 5 $90.2B 1 $105M

By Geo

State/Country Buy Value Sell Value
United States 5 90.2B 1 105M
  California 2 26.8B - -
  Washington 1 - - -
  New Jersey 1 63.0B - -
Total 5 $90.2B 1 $105M

Top M&A Advisors

Financial Deals
Morgan Stanley
PJT Partners, Inc.
Legal Deals
Kirkland & Ellis LLP
Wachtell, Lipton, Rosen & Katz LLP
McCann FitzGerald

Deal Values

buy # Total
> $1B 3 $89.8B
$100M to $1B 1 $350M
TOTAL $90.2B
Largest Allergan plc
$63.0B (2019-06-25)
sell # Total
$100M to $1B 1 $105M
Largest Rare Pediatric Disease Priority Review Voucher (PPRV)
$105M (2020-12-28)

M&A Connections

Acquired from
1 (20%)
Divested to
1 (100%)

 Subscribe to unlock this and 171,590
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 4.2K Private Equity Firms
  • 161K M&A Transactions
  • 167K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.4K M&A Advisors
    (Investment Banks and Law Firms)
  • 59K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.